Latest news with #Deceuninck
Yahoo
11-06-2025
- Business
- Yahoo
European Penny Stocks Under €2B Market Cap: 3 Hidden Gems To Watch
As the European markets experience a boost with the pan-European STOXX Europe 600 Index rising by 0.90% amid slowing inflation and easing ECB monetary policy, investors are exploring opportunities in less conventional areas. Though 'penny stocks' might sound like a relic from past trading days, they still offer relevant opportunities for those interested in smaller or newer companies. With strong financials, these stocks can provide a mix of affordability and growth potential, making them an intriguing option for investors seeking hidden value. Name Share Price Market Cap Financial Health Rating KebNi (OM:KEBNI B) SEK1.832 SEK496.76M ★★★★★★ Angler Gaming (NGM:ANGL) SEK3.66 SEK274.45M ★★★★★★ Cellularline (BIT:CELL) €3.18 €67.07M ★★★★★☆ Fondia Oyj (HLSE:FONDIA) €4.65 €17.39M ★★★★★★ Abak (WSE:ABK) PLN4.20 PLN11.32M ★★★★★★ Bredband2 i Skandinavien (OM:BRE2) SEK2.415 SEK2.31B ★★★★☆☆ Hifab Group (OM:HIFA B) SEK3.60 SEK219.02M ★★★★★★ Euroland Société anonyme (ENXTPA:MLERO) €3.26 €9.49M ★★★★★★ Deceuninck (ENXTBR:DECB) €2.20 €303.74M ★★★★★★ Netgem (ENXTPA:ALNTG) €0.976 €32.68M ★★★★★★ Click here to see the full list of 446 stocks from our European Penny Stocks screener. We're going to check out a few of the best picks from our screener tool. Simply Wall St Financial Health Rating: ★★★★★★ Overview: Deceuninck NV is involved in the design, manufacture, recycling, and distribution of multi-material window, door, and building solutions across Europe, North America, Turkey, and other international markets with a market cap of €303.74 million. Operations: The company's revenue is primarily generated from its Window and Door Systems segment at €759.81 million, followed by Home Protection at €40.48 million, and Outdoor Living at €26.70 million. Market Cap: €303.74M Deceuninck NV, with a market cap of €303.74 million, shows promising financial health for a penny stock. Its earnings have grown significantly by 46.6% over the past year, outpacing the industry average and its five-year growth rate of 5.1%. The company's interest payments are well covered by EBIT at 9.8x coverage, and its net debt to equity ratio is satisfactory at 16.7%. While Deceuninck's return on equity is low at 4.5%, it trades below fair value estimates by approximately 24.8%. Recent dividend announcements affirm a cash dividend of €0.056 per share payable in May 2025. Jump into the full analysis health report here for a deeper understanding of Deceuninck. Learn about Deceuninck's future growth trajectory here. Simply Wall St Financial Health Rating: ★★★★☆☆ Overview: Metsä Board Oyj operates in the folding boxboard, fresh fibre linerboard, and market pulp sectors both in Finland and internationally, with a market cap of €1.24 billion. Operations: The company generates €1.94 billion in revenue from its operations in the folding boxboard, fresh fibre linerboard, and market pulp sectors. Market Cap: €1.24B Metsä Board Oyj, with a market cap of €1.24 billion, presents a mixed profile for investors in the penny stock segment. The company's net debt to equity ratio is satisfactory at 20.6%, and its short-term assets exceed both short-term and long-term liabilities, indicating sound liquidity management. However, the return on equity remains low at 1%, and recent earnings show a net loss of €7 million compared to last year's profit. Despite negative earnings growth over the past year, Metsä Board trades significantly below estimated fair value and has recently issued green bonds worth €200 million to finance sustainable projects. Click to explore a detailed breakdown of our findings in Metsä Board Oyj's financial health report. Review our growth performance report to gain insights into Metsä Board Oyj's future. Simply Wall St Financial Health Rating: ★★★★☆☆ Overview: Xbrane Biopharma AB is a biotechnology company focused on developing, manufacturing, and selling biosimilars, with a market capitalization of SEK413.69 million. Operations: Xbrane Biopharma generates revenue from its Biosimilar Development segment, totaling SEK277.89 million. Market Cap: SEK413.69M Xbrane Biopharma, with a market cap of SEK413.69 million, offers an intriguing yet volatile opportunity in the penny stock landscape. Despite being unprofitable and facing increased volatility, Xbrane has shown significant revenue growth, reporting SEK93.24 million in Q1 2025 compared to SEK14.07 million a year prior. The company's recent follow-on equity offering of SEK200 million aims to bolster its cash runway beyond the current two months. While auditor concerns about its going concern status persist, strategic advancements like the FDA review for its biosimilar candidate could potentially influence future prospects if approvals are secured by October 2025. Click here to discover the nuances of Xbrane Biopharma with our detailed analytical financial health report. Explore Xbrane Biopharma's analyst forecasts in our growth report. Take a closer look at our European Penny Stocks list of 446 companies by clicking here. Want To Explore Some Alternatives? AI is about to change healthcare. These 22 stocks are working on everything from early diagnostics to drug discovery. The best part - they are all under $10b in market cap - there's still time to get in early. This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned. Companies discussed in this article include ENXTBR:DECB HLSE:METSB and OM:XBRANE. This article was originally published by Simply Wall St. Have feedback on this article? Concerned about the content? with us directly. Alternatively, email editorial-team@ Sign in to access your portfolio
Straits Times
15-05-2025
- Sport
- Straits Times
Groves triumphs in sprint as Giro stage six neutralised after crash
Cycling - Giro d'Italia - Stage 6 - Potenza to Naples - Italy - May 15, 2025 Alpecin - Deceuninck's Kaden Groves in action before crossing the finish line to win stage 6 REUTERS/Jennifer Lorenzini Cycling - Giro d'Italia - Stage 6 - Potenza to Naples - Italy - May 15, 2025 Alpecin - Deceuninck's Kaden Groves celebrates on the podium after winning stage 6 REUTERS/Jennifer Lorenzini NAPLES - Kaden Groves of Alpecin–Deceuninck won the sixth stage of the Giro d'Italia in a sprint finish on Thursday after the stage was neutralised following a huge crash in wet conditions on the 227 km ride from Potenza to Naples. The longest stage of this year's Giro had only a winner to celebrate as the crash which occurred with about 70 km to go forced organisers to make the decision not to award points, time gaps or bonuses. Groves crossed the finish line a few seconds shy of five hours on the road, ahead of Cofidis rider Milan Fretin. Paul Magnier of Soudal Quick-Step, who had also crashed earlier in the stage, finished third. "It's a big relief. The team always believed in me. It's not been a great start of the season, but then with the injury I missed a lot of racing. I arrived here without a win, so getting the first one for the year is a big relief," Groves said. "These wet roads are quite slippery, knowing the cobbles starting around the two-km mark was super important to be in front. But in the end, we also needed to use some guys early to chase, close the breakaway, they did a super ride. "Once it started raining, I felt quite a bit better actually. I'm quite good in the colder, wetter conditions." The peloton was 47 seconds behind the lead duo of Enzo Paleni and Taco van der Hoorn when several riders in the bunch - including former Giro winners Jai Hindley and Richard Carapaz - crashed on the slippery road. The race was neutralised and the peloton slowed down by the race director before it resumed with nothing on offer apart from a stage win. Hindley, the 2022 Giro winner, was sat by the side of the road and the 29-year-old, clearly in pain, was forced to abandon as he eventually got into an ambulance for treatment. Carapaz, whose jersey had been torn in the fall, rejoined the peloton while Soudal Quick-Step's Josef Cerny had to abandon the race as well. Bahrain Victorious' Rainer Kepplinger was taken to hospital with an injured finger, cuts and bruises while his teammate Max van der Meulen will undergo medical tests later in the day. With teams opting not to take any risks until the finale, they eventually caught up with the lead duo with less than three kilometres to go while Mads Pedersen, who has won three stages, eased up and did not sprint to the finish. However, he retained the race lead, with the Danish rider holding a 17-second advantage over Primoz Roglic. REUTERS Join ST's Telegram channel and get the latest breaking news delivered to you.
The Star
15-05-2025
- Sport
- The Star
Cycling-Groves triumphs as Giro stage six neutralised after crash
Cycling - Giro d'Italia - Stage 6 - Potenza to Naples - Italy - May 15, 2025 Alpecin - Deceuninck's Kaden Groves celebrates winning stage 6 REUTERS/Jennifer Lorenzini NAPLES (Reuters) - Kaden Groves of Alpecin–Deceuninck won the sixth stage of the Giro d'Italia in a sprint finish on Thursday after the stage was neutralised following a huge crash in wet conditions on the 227 km ride from Potenza to Naples. The longest stage of this year's Giro had only a winner to celebrate as the crash which occurred with about 70 km to go led to organisers making the decision not to award points, time gaps or bonuses. Groves crossed the finish line a few seconds shy of five hours on the road, ahead of Cofidis rider Milan Fretin. Paul Magnier of Soudal-QuickStep, who had also crashed earlier in the stage, finished third. Mads Pedersen, who has won three stages, retained the race lead and the pink jersey. (Reporting by Rohith Nair in Bengaluru; Editing by Toby Davis)
Yahoo
13-05-2025
- Yahoo
Man accused of drunkenly running over woman in Pike County campground
HENDERSON, Ky (WEHT) – A man from Beaver Dam is charged with attempted murder in Pike County after allegedly running over his friend during an argument. According to an affidavit, Pike County Central Dispatch received a call that two people were believed to be intoxicated in a Pike State Forest Campground campsite next to him. The caller also claimed one of them drove their car into a tent. Officials state when authorities arrived, a white Chevrolet Impala was seen with flattened front end, a concrete picnic table was damaged and a tent that was flattened. A man reportedly stumbled over to a Pike County deputy and claimed he and a friend got into an argument over pants. The male was later identified as Travis Deceuninck. Deceuninck went on to claim he asked his friend to bring him new pants because he soiled himself, and he was taking her to North Carolina to 'get fixed'. Deceuninck also said he had picked her up in his car three times and was chaotic each time because of her behavior. Officials state Deceuninck later admitted he and his friend had been drinking heavily. The female was identified as Megan Manson. She claimed they were arguing about one of the dogs. She also claimed Deceuninck got into his car, drove over the tent and into the picnic table, causing the picnic table to collapse. Manson claimed she was trying to save one of her dogs from getting hurt. She was complaining of several injuries with one of her socks being soaked in blood with an abnormal lump. EMS believed that her foot was broken. She was taken to an area hospital. Deceuninck was detained, and during a portable breath test, a reading claimed Deceuninck's BAC level was .330. After getting medical clearance, Deceuninck was booked into the Pike County Jail for Attempted Murder, Battery-Deadly Weapon, Battery-Serious Bodily Injury and Criminal Mischief. Copyright 2025 Nexstar Media, Inc. All rights reserved. This material may not be published, broadcast, rewritten, or redistributed.
Yahoo
13-02-2025
- Business
- Yahoo
Deceuninck And Two Other Promising Penny Stocks To Watch
As global markets navigate the complexities of tariff uncertainties and fluctuating economic indicators, investors are keenly observing potential opportunities amidst the broader market dynamics. Penny stocks, a term that may feel somewhat antiquated, continue to hold relevance as they often represent smaller or newer companies with untapped growth potential. In this article, we explore three intriguing penny stocks that stand out for their financial resilience and growth prospects, offering investors a chance to discover under-the-radar opportunities in today's market landscape. Name Share Price Market Cap Financial Health Rating Bosideng International Holdings (SEHK:3998) HK$3.85 HK$44.77B ★★★★★★ DXN Holdings Bhd (KLSE:DXN) MYR0.53 MYR2.73B ★★★★★★ Polar Capital Holdings (AIM:POLR) £4.945 £476.68M ★★★★★★ Warpaint London (AIM:W7L) £3.99 £321.93M ★★★★★★ Datasonic Group Berhad (KLSE:DSONIC) MYR0.33 MYR959.84M ★★★★★★ Begbies Traynor Group (AIM:BEG) £0.934 £148.85M ★★★★★★ Hil Industries Berhad (KLSE:HIL) MYR0.85 MYR283.81M ★★★★★★ MGB Berhad (KLSE:MGB) MYR0.70 MYR414.16M ★★★★★★ Lever Style (SEHK:1346) HK$1.13 HK$717.31M ★★★★★★ Embark Early Education (ASX:EVO) A$0.79 A$144.95M ★★★★☆☆ Click here to see the full list of 5,706 stocks from our Penny Stocks screener. Underneath we present a selection of stocks filtered out by our screen. Simply Wall St Financial Health Rating: ★★★★★☆ Overview: Deceuninck NV is involved in the design, manufacture, recycling, and distribution of multi-material window, door, and building solutions across Europe, North America, Turkey, and other international markets with a market cap of €330.76 million. Operations: The company's revenue is primarily derived from its Window and Door Systems segment, which accounts for €788.34 million, followed by Home Protection at €44.13 million and Outdoor Living at €27.98 million. Market Cap: €330.76M Deceuninck NV, with a market cap of €330.76 million, has faced financial challenges recently, including a significant €19.7 million one-off loss impacting its latest results. Despite past profit growth averaging 13.8% annually over five years, the company experienced negative earnings growth last year and reduced net profit margins to 0.2%. While trading at a good value relative to peers and industry, Deceuninck's high debt levels are concerning, though operating cash flow covers debt well at 39.6%. The management team is relatively new with an average tenure of 1.1 years, indicating potential for strategic shifts ahead. Jump into the full analysis health report here for a deeper understanding of Deceuninck. Learn about Deceuninck's future growth trajectory here. Simply Wall St Financial Health Rating: ★★★★★☆ Overview: Yoma Strategic Holdings Ltd. is an investment holding company operating in real estate, motor, leasing, mobile financial services, food and beverages, and other investments across Singapore, Myanmar, and the People's Republic of China with a market cap of SGD188.72 million. Operations: The company's revenue segments include Myanmar - Leasing ($7.83 million), Yoma F&B in Myanmar ($30.52 million), Investments across Myanmar/PRC ($7.92 million), Yoma Land Services in Myanmar ($16.54 million), Yoma Land Development in Myanmar ($99.09 million), Mobile Financial Services in Myanmar ($38.67 million), and Yoma Motors excluding Financial Services in Myanmar ($10.07 million). Market Cap: SGD188.72M Yoma Strategic Holdings Ltd., with a market cap of SGD188.72 million, has transitioned to profitability in the past year, driven by diverse revenue streams across Myanmar and China. However, its recent financials were notably impacted by a one-off gain of $42.9M, complicating earnings comparisons. The company's short-term assets ($405.2M) comfortably cover its liabilities, and debt management appears prudent with a net debt to equity ratio of 11.8%. Despite stable weekly volatility at 10%, its share price remains highly volatile over the past three months. While interest coverage is low at 2.1x EBIT, operating cash flow adequately covers debt obligations at 29.8%. Dive into the specifics of Yoma Strategic Holdings here with our thorough balance sheet health report. Gain insights into Yoma Strategic Holdings' historical outcomes by reviewing our past performance report. Simply Wall St Financial Health Rating: ★★★★★★ Overview: Zhejiang Juli Culture Development Co., Ltd. operates in the cultural industry and has a market capitalization of CN¥2.31 billion. Operations: No revenue segments have been reported for the company. Market Cap: CN¥2.31B Zhejiang Juli Culture Development Co., Ltd. has shown significant financial improvement, becoming profitable this year with a high Return on Equity of 36%. The company is debt-free, enhancing its financial stability, and its short-term assets (CN¥596.7M) exceed both short-term (CN¥333.9M) and long-term liabilities (CN¥46.5M). Despite being pre-revenue in the cultural industry, it has maintained a stable weekly volatility of 8%, indicating consistent performance. Its Price-To-Earnings ratio of 10.5x suggests potential value compared to the broader Chinese market average of 37.1x, though investors should consider the high level of non-cash earnings reported. Unlock comprehensive insights into our analysis of Zhejiang Juli Culture DevelopmentLtd stock in this financial health report. Review our historical performance report to gain insights into Zhejiang Juli Culture DevelopmentLtd's track record. Navigate through the entire inventory of 5,706 Penny Stocks here. Hold shares in these firms? Setup your portfolio in Simply Wall St to seamlessly track your investments and receive personalized updates on your portfolio's performance. Enhance your investing ability with the Simply Wall St app and enjoy free access to essential market intelligence spanning every continent. Explore high-performing small cap companies that haven't yet garnered significant analyst attention. Jump on the AI train with fast growing tech companies forging a new era of innovation. Find companies with promising cash flow potential yet trading below their fair value. This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned. Companies discussed in this article include ENXTBR:DECB SGX:Z59 and SZSE:002247. Have feedback on this article? Concerned about the content? with us directly. Alternatively, email editorial-team@ Sign in to access your portfolio
